Harding Loevner Global Equity Portfolio's EBIT is $-28M, below the sector sector average of $-25M.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024
The latest EBIT for HLMGX is $-28M as of March 2024. That compares with $-14M in the prior-year period — down 99.2% year over year. That is below the sector sector average of $-25M. Investors often review this figure alongside Harding Loevner Global Equity Portfolio's historical trend and sector peers before judging valuation or financial health.
Over the past year, HLMGX's EBIT moved from $-14M to $-28M — a 99.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harding Loevner Global Equity Portfolio's operating scale or balance-sheet position.
Against its sector companies, HLMGX currently prints $-28M for EBIT, while the sector average sits near $-25M. That is roughly 9.4% below the sector mean. Large gaps often invite a closer look at Harding Loevner Global Equity Portfolio's growth, margins, and balance sheet.
A EBIT figure of $-28M for HLMGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.
After noting HLMGX's EBIT ($-28M), review year-over-year change from $-14M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.